Home
ESC TV Conversations - SGLT2 inhibitors – wonder drugs in Heart Failure and beyond?
European Society of Cardiology
29 ส.ค. 2022
การดู 9,803 ครั้ง
The serendipitous story of SGLT2i in the treatment of heart failure
ESC TV Conversations - Heart failure treatment 10 years from now
Basic Mechanisms of SGLT2 inhibitors in the Kidney
SGLT2 Inhibitors in Acute Heart Failure The Earlier The Better DICTATE AHF
ESC 23 Late-Breaker Discussion: The ECLS-Shock Trial
SGLT2 Inhibitors vs GLP-1 Agonists: A Cardiologist and an Endocrinologist Weigh In
ESC TV at #ESCCongress 2021 - 2021 ESC Guidelines on heart failure
A Tale of Salt and Sugar: SGLT2 Inhibitors in Cardiovascular Disease
Heart Failure at ESC 2023: Recapitulations, Postulations, Predictions
Is AF Ablation the Fifth Pillar in Heart Failure Care CASTLE HTx
Impact of the New Heart Failure Guidelines
When Should We Use SGLT2 Inhibitors?
ACC Cardiology Hour From ESC Congress 2023
Choosing SGLT2 Inhibitors vs GLP-1 Receptor Agonists
Heart Failure With an Improved Left Ventricular Ejection Fraction | Douglas Mann, MD
SGLT2 Inhibitors and Heart Failure
2023 ESC Guidelines Update: Acute & Chronic Heart Failure
SGLT2 Inhibitors in Patients Without Diabetes at Risk of HF
Best Practices for Starting SGLT2 Inhibitors in HFpEF Treatment
ESC TV Conversations - Coronary intervention 2022: what are the remaining questions?